Palantir Technologies finds itself at a crossroads this week, buffeted by two opposing forces. A favorable court ruling provides a tailwind by strengthening its protections for intellectual property and personnel. Simultaneously, a Pentagon directive threatens to impose a costly restructuring within a key defense contract. The company’s operational agility is now under scrutiny as it attempts to manage these concurrent challenges.
Operational Strength Meets Market Noise
Fundamentally, Palantir is coming off a period of robust performance. Fourth-quarter revenue surged 70% to approximately $1.41 billion, while its non-GAAP adjusted earnings per share jumped 79% to $0.25. This growth was largely fueled by demand for its artificial intelligence platform, with commercial sector revenue from U.S. customers soaring 137% and sales to U.S. government clients increasing 66%.
Market sentiment has also seen a shift. Analysts at UBS upgraded the stock from “Neutral” to “Buy,” setting a price target of $180. The bank cited the recent share price pullback, an improved risk-reward profile, and raised revenue expectations for 2026—now projected at about $7.19 billion.
However, other developments have created background noise. Between February 20 and March 3, 2026, insider sales by CEO Alex Karp and board member Peter Thiel reportedly totaled over $400 million, some of which were pre-planned transactions. From a technical perspective, the stock appears to have experienced significant momentum, with its 14-day Relative Strength Index (RSI) reading of 78.8 indicating a strong near-term trend. Shares closed at €135.40 on Friday.
Court Injunction Blocks Talent Poaching
The positive signal emerged from a U.S. federal courtroom, where Palantir secured a legal victory. The company obtained a preliminary injunction preventing three former employees from recruiting its staff or utilizing confidential information for the AI startup Percepta AI.
Should investors sell immediately? Or is it worth buying Palantir?
Presiding Judge J. Paul Oetken found it likely that Percepta CEO Hirsh Jain and co-founder Radha Jain breached agreements not to solicit personnel from their former employer. The ruling also suggested a recruited software developer may have violated a confidentiality agreement. Judge Oetken justified the court’s intervention by stating Palantir otherwise faced a threat of “irreparable harm.” The order did, however, deem some of Palantir’s non-compete clauses overly broad, allowing certain individuals to remain at Percepta AI, a company backed by venture firm General Catalyst.
Pentagon Mandate Forces Costly Platform Overhaul
Beneath the surface, the situation grows more complex. According to Reuters, Palantir’s military AI platform, “Maven Smart Systems,” is under pressure following a Pentagon instruction for contractors to cease business relations with Anthropic. This stems from the U.S. Department of Defense classifying Anthropic as a supply chain national security risk, barring it from further military business and requiring its AI services be replaced in all defense projects.
For Palantir, this translates to a concrete operational hurdle: workflows within Maven that currently rely on Anthropic’s “Claude” model must be migrated to alternative AI models. One source indicated that portions of the platform may need to be rebuilt to facilitate this change. The stakes are high due to the contract’s scale; agreements related to Maven with the Defense Department and other security agencies could hold a potential value exceeding $1 billion.
While Palantir emphasizes a “multi-model” approach—where its platform supports various large language models—Claude was reportedly the sole authorized and optimized provider for certain classified Maven workflows. A potential grace period offers some relief; the Pentagon is likely to allow Anthropic to continue providing services for up to six months during the transition. This window gives Palantir breathing room, but the technical overhaul remains a significant execution challenge.
The coming months will serve as a critical stress test. Palantir must successfully replace Claude in sensitive defense applications within this six-month timeframe while simultaneously sustaining its recent explosive growth in the U.S. commercial business.
Ad
Palantir Stock: Buy or Sell?! New Palantir Analysis from March 9 delivers the answer:
The latest Palantir figures speak for themselves: Urgent action needed for Palantir investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from March 9.
Palantir: Buy or sell? Read more here...









